Phillips, A. N., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D., Wensing, A., Lundgren, J. D., De Luca, A., Pillay, D., Mellors, J., Cambiano, V., Bansi-Matharu, L., Nakagawa, F., Kalua, T., Jahn, A., Apollo, T., Mugurungi, O., Clayden, P., Gupta, R. K., Barnabas, R., Revill, P., Cohn, J., Bertagnolio, S., & Calmy, A. (2019). risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Lancet, 6(2), e116–e127. http://access.bl.uk/ark:/81055/vdc_100077367641.0x000001